Growth Opportunities in the APAC IVD Market, Forecast to 2021

Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016.

Research Scope:
•     Key trends and opportunities in the IVD market, which has been segmented into 8 major divisions:
o     Immunochemistry
o     Self-monitoring Blood Glucose (SMBG) Meter
o     Hematology
o     Point-of-care Testing (POCT)
o     Tissue Diagnostics
o     Hemostasis
o     Clinical Microbiology
o     Molecular Diagnostics

•     Regional trends in APAC; it covers China, India, Japan, Australia, South Korea, and member states of the Association of Southeast Asian Nations (ASEAN)

The APAC IVD industry is undergoing major transformation. Paradigm shifts in the Asian healthcare ecosystem are driving the future of the IVD industry with stellar growth rates and rampant uptake of innovative technologies. Market penetration of molecular diagnostic (MDx) tests in infectious disease diagnosis, laboratory automation for high throughput operational efficiency, and digital pathology are three major themes that will impact the future of clinical pathology in Asia. The spurt in the number of private healthcare sectors and market shift towards quality care, private insurance, and high demand for medical tourism have led Asia to be on par with western counterparts in terms of availability and access to novel technologies. However, given the huge potential and market opportunities, there remain significant challenges in the complex market with preferential demands in Asian countries and fluidic regulatory and market access networks that pose significant challenges for operating companies. The APAC IVD industry, worth $ 14.44 billion in 2016, is expected to reach $19.64 billion in 2021 growing at a CAGR of 6.3%. In molecular diagnostics, infectious disease has the highest market share of 72.0%, followed by oncology (14.3%), genetic disorders (10.0%), and pharmacogenomics (3.7%). Digital innovations in the IVD industry, such as digital pathology, precision medicine, and health analytics are radically changing the care continuum in APAC. The IVD market is moving towards total laboratory automation from task-targeted automation. Although stand-alone automation systems are cost effective in clinical labs, multiple stakeholders in the healthcare ecosystems including physicians, payers, and administrators demand “connected-pathology solutions.”

Key Questions This Study will Answer:
1.     What is the current IVD market scenario in Asia?
2.     What are the emerging segments in Asia?
3.     What are the hot beds in Asia for investment in diagnostics?
4.     What are the regional dynamics that impact the growth of the IVD industry?
5.     What is the penetration of novel diagnostic solutions across the care continuum pathway?

Table of Contents

1. Executive Dashboard
Purpose of this Growth Opportunity Study
Scope and Segmentation
5-step Process to Transformational Growth
Key Findings—How is this Market Important to You?
Market Engineering Measurements
8 Big Market Themes for APAC IVD Market
2. Growth Environment—Market Overview
Research Methodology
Market Overview
APAC IVD Industry—Regional Perspective
Key Regulatory Trends—APAC
Market Drivers
Market Restraints
Industry Challenges
3. Market Forecasts
APAC IVD Market—Market Engineering Measurements
APAC IVD Market—Revenue Forecast
4. Competitive Playbook
Market Snapshot
Market Share Analysis
Visioning Scenarios
Companies to Watch—JN Medsys
Companies to Watch—Quantum Biosystems
Companies to Watch—Medisensor Inc.
Companies to Watch—Clearbridge BioMedics
Companies to Watch—Volition Rx
Companies to Watch (Tech Innovation)
Mergers, Acquisitions, and Strategic Partnerships
5. Growth Pipeline, Strategy, and Implementation
Growth Opportunity—Digital Pathology
Growth Opportunity—Centralized Clinical Labs
Growth Opportunity—Super Specialty Clinics
Growth Opportunity—Diagnostic Data Management
Growth Opportunity—E-Commerce Model
Growth Opportunity—Clinical Lab Automation
Growth Opportunity—Clinical Trials
Growth Opportunity—Infectious Disease
Growth Opportunity—Molecular Diagnostics
Top Predictions for the APAC IVD Market
Strategic Imperatives for APAC IVD Companies
6. Regional Dynamics
Percent Revenue by Country
Revenue by Country
China
Japan
South Korea
India
Australia
ASEAN Overview
7. Segment Analysis
Immunochemistry—Revenue Forecast
Immunochemistry—Key Trends
Immunochemistry—Opportunity Assessment and Case Study
Immunochemistry—Market Share Analysis
Immunochemistry—Snapshot of Market Participants
Molecular Diagnostics (MDx)—Revenue Forecast
Molecular Diagnostics (MDx)—Percent Revenue by Application
Molecular Diagnostics (MDx)—Key Trends
Molecular Diagnostics (MDx)—Market Share Analysis
Molecular Diagnostics (MDx)—Snapshot of Market Participants
SMBG—Revenue Forecast
SMBG—Key Trends
SMBG—Market Share Analysis
SMBG—Snapshot of Market Participants
POCT—Revenue Forecast
POCT—Percent Revenue by Application
POCT—Key Trends
POCT—Market Share Analysis
POCT—Snapshot of Market Participants
Hematology—Revenue Forecast
Hematology—Key Trends
Hematology—Case Study
Hematology—Market Share Analysis
Hematology—Snapshot of Market Participants
Tissue Diagnostics—Revenue Forecast
Tissue Diagnostics—Key Trends
Tissue Diagnostics—Market Share Analysis
Tissue Diagnostics—Snapshot of Market Participants
Hemostasis—Revenue Forecast
Hemostasis—Key Trends
Hemostasis—Market Share Analysis
Hemostasis—Snapshot of Market Participants
Clinical Microbiology—Revenue Forecast
Clinical Microbiology—Key Trends
8. The Last Word
Key Conclusions
Legal Disclaimer

Infographic



List of Figures & Charts

1. IVD Market: Key Market Drivers, APAC, 2017–2021
2. IVD Market: Key Market Restraints, APAC, 2017–2021
3. IVD Market: Industry Challenges, APAC, 2016–2021
4. IVD Market: Market Engineering Measurements, APAC, 2016
5. IVD Market: Multi-faceted Growth, APAC, 2016–2021
6. IVD Market: Revenue by Country, APAC, 2016
7. IVD Market: Key Market Participants in Immunochemistry, APAC, 2016
8. IVD Market: Key Market Participants in Molecular Diagnostics, APAC, 2016
9. IVD Market: Key Market Participants in SMBG, APAC, 2016
10. IVD Market: Key Market Participants in POCT, APAC, 2016
11. IVD Market: Key Market Participants in Hematology, APAC, 2016
12. IVD Market: Key Market Participants in Tissue Diagnostics, APAC, 2016
13. IVD Market: Key Market Participants in Hemostasis, APAC, 2016


1. IVD Market: Market Engineering Measurements, APAC, 2016
2. IVD Market: Revenue Forecast, APAC, 2015–2021
3. IVD Market: Percent of Revenue by Participants, APAC, 2016
4. IVD Market: Percent Revenue by Country, APAC, 2016
5. IVD Market: Revenue Forecast for Immunochemistry, APAC, 2015–2021
6. IVD Market: Market Share Analysis in Immunochemistry, APAC, 2016
7. IVD Market: Revenue Forecast for Molecular Diagnostics, APAC, 2015–2021
8. IVD Market: Percent Revenue by Application in Molecular Diagnostics, APAC, 2016
9. IVD Market: Market Share Analysis in Molecular Diagnostics, APAC, 2016
10. IVD Market: Revenue Forecast for SMBG, APAC, 2015–2021
11. IVD Market: Market Share Analysis in Molecular Diagnostics, APAC, 2016
12. IVD Market: Revenue Forecast for POCT, APAC, 2015–2021
13. IVD Market: Percent Revenue by Application in POCT, APAC, 2016
14. IVD Market: Market Share Analysis in POCT, APAC, 2016
15. IVD Market: Revenue Forecast for Hematology, APAC, 2015–2021
16. IVD Market: Improvement in Overall Performance Metrics Following Implementation of Lab Automation, APAC, 2017–2021
17. IVD Market: Market Share Analysis in Hematology Diagnostics, APAC, 2016
18. IVD Market: Revenue Forecast for Tissue Diagnostics, APAC, 2015–2021
19. IVD Market: Market Share Analysis in Tissue Diagnostics, APAC, 2016
20. IVD Market: Revenue Forecast for Hemostasis, APAC, 2015–2021
21. IVD Market: Market Share Analysis in Hemostasis Diagnostics, APAC, 2016
22. IVD Market: Revenue Forecast for Clinical Microbiology, APAC, 2015–2021



Related Research

Release Date : 23-Mar-17

Region : Asia Pacific

Release Date : 02-Dec-16

Region : Asia Pacific

Release Date : 14-Nov-16

Region : Asia Pacific

Release Date : 11-Nov-16

Region : Asia Pacific

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.